Inhibrx Biosciences, Inc. ($INBX)
Filing Information
| Accession Number | 0001366074-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Sep 28, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
10,000
Total Value
$998,783.69
P&L
+1.8% (+$18,316.31)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | Sep 25, 2026 | Purchase | 3,324 | $98.87 | $328,630.25 | 733,872 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 25, 2026 | Purchase | 2,176 | $99.60 | $216,726.99 | 736,048 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 28, 2026 | Purchase | 1,500 | $98.88 | $148,320.45 | 737,548 | Indirect | By the Lappe Family Trust | View Details | |
Director | Common Stock | โ | Sep 28, 2026 | Purchase | 3,000 | $101.70 | $305,106.00 | 740,548 | Indirect | By the Lappe Family Trust | View Details |